Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Chin

Showing results (591-600 of 608) with videos related to

Pageof 61
Sort By:
Cell Metabolism|July 21, 2015
2-Hydroxyglutarate Inhibits ATP Synthase and mTOR SignalingXudong Fu, Randall M Chin, Laurent Vergnes, et al.
Pediatric Neurology|June 1, 2019
Severity Assessment in CDKL5 Deficiency DisorderScott Demarest, Elia M Pestana-Knight, Heather E Olson, et al.
Science Translational Medicine|March 16, 2018
Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2Joao Incio, Jennifer A Ligibel, Daniel T McManus, et al.
JCI Insight|July 3, 2019
S100a4-Cre-mediated deletion of Patched1 causes hypogonadotropic hypogonadism: role of pituitary hematopoietic cells in endocrine regulationYi Athena Ren, Teresa Monkkonen, Michael T Lewis, et al.
Cancer Discovery|June 2, 2016
Obesity-Induced Inflammation and Desmoplasia Promote Pancreatic Cancer Progression and Resistance to ChemotherapyJoao Incio, Hao Liu, Priya Suboj, et al.
Advances in Therapy|August 11, 2025
Seralutinib for the Treatment of Pulmonary Arterial Hypertension in Adults: TORREY Open-Label Extension StudyOlivier Sitbon, Sandeep Sahay, Pilar Escribano Subías, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 23, 2015
Phase I and biomarker study of OPB-51602, a novel signal transducer and activator of transcription (STAT) 3 inhibitor, in patients with refractory solid malignanciesA L Wong, R A Soo, D S Tan, et al.
The Lancet. Respiratory Medicine|May 5, 2024
Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trialRobert P Frantz, Vallerie V McLaughlin, Sandeep Sahay, et al.
Molecular Cancer Therapeutics|August 23, 2019
Preclinical Efficacy and Safety Comparison of CD3 Bispecific and ADC Modalities Targeting BCMA for the Treatment of Multiple MyelomaSiler H Panowski, Tracy C Kuo, Yi Zhang, et al.
Development (Cambridge, England)|February 23, 2018
Identification, isolation and characterization of human LGR5-positive colon adenoma cellsMichael K Dame, Durga Attili, Shannon D McClintock, et al.
Pageof 61

Showing results (591-600 of 608) with videos related to

Sort By:
Pageof 61
Cell Metabolism|July 21, 2015
2-Hydroxyglutarate Inhibits ATP Synthase and mTOR SignalingXudong Fu, Randall M Chin, Laurent Vergnes, et al.
Pediatric Neurology|June 1, 2019
Severity Assessment in CDKL5 Deficiency DisorderScott Demarest, Elia M Pestana-Knight, Heather E Olson, et al.
Science Translational Medicine|March 16, 2018
Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2Joao Incio, Jennifer A Ligibel, Daniel T McManus, et al.
JCI Insight|July 3, 2019
S100a4-Cre-mediated deletion of Patched1 causes hypogonadotropic hypogonadism: role of pituitary hematopoietic cells in endocrine regulationYi Athena Ren, Teresa Monkkonen, Michael T Lewis, et al.
Cancer Discovery|June 2, 2016
Obesity-Induced Inflammation and Desmoplasia Promote Pancreatic Cancer Progression and Resistance to ChemotherapyJoao Incio, Hao Liu, Priya Suboj, et al.
Advances in Therapy|August 11, 2025
Seralutinib for the Treatment of Pulmonary Arterial Hypertension in Adults: TORREY Open-Label Extension StudyOlivier Sitbon, Sandeep Sahay, Pilar Escribano Subías, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 23, 2015
Phase I and biomarker study of OPB-51602, a novel signal transducer and activator of transcription (STAT) 3 inhibitor, in patients with refractory solid malignanciesA L Wong, R A Soo, D S Tan, et al.
The Lancet. Respiratory Medicine|May 5, 2024
Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trialRobert P Frantz, Vallerie V McLaughlin, Sandeep Sahay, et al.
Molecular Cancer Therapeutics|August 23, 2019
Preclinical Efficacy and Safety Comparison of CD3 Bispecific and ADC Modalities Targeting BCMA for the Treatment of Multiple MyelomaSiler H Panowski, Tracy C Kuo, Yi Zhang, et al.
Development (Cambridge, England)|February 23, 2018
Identification, isolation and characterization of human LGR5-positive colon adenoma cellsMichael K Dame, Durga Attili, Shannon D McClintock, et al.
Pageof 61